Last reviewed · How we verify
High-dose esketamine infusion
At a glance
| Generic name | High-dose esketamine infusion |
|---|---|
| Sponsor | Anqing Municipal Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Intraoperative Multimodal Monitoring as a Means in Reducing the Duration of Mechanical Ventilation in High-Risk Patients Undergoing Major Abdominal Procedures - A Pilot Study (NA)
- The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery (NA)
- Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery (PHASE4)
- Different Dose Esketamine and Dexmedetomidine for Supplemental Analgesia and Longterm Outcomes (PHASE4)
- Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy (NA)
- Effect of Low-dose EsketaMine on dElirium in High-risk Elderly Patients uNdergoing elecTive Surgery (ELEMENT) (NA)
- Venous Cannulation Pain to Guide Choice of Anesthetic Method (NA)
- ESKETamine for FIBromyalgia Treatment (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High-dose esketamine infusion CI brief — competitive landscape report
- High-dose esketamine infusion updates RSS · CI watch RSS
- Anqing Municipal Hospital portfolio CI